Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the launch of new red, black and blue 400nm LATEX conjugation kits. Innova Biosciences’ LATEX conjugation kits are one-step kits for the covalent conjugation of antibodies and proteins to specially treated latex beads, for use in the diagnostics field and across other applications.
The new conjugation kits are easy to use, and offer quick, effective conjugation of antibodies, proteins and peptides to latex beads, offering the potential to simplify and improve assay development whilst reducing development timelines. Additionally, as a variety of colours are available, the range enables multiplexing and therefore maximum flexibility in assay design. The kits are suitable for use in development of diagnostics, in lateral flow assays, and across a range of other applications, and are fully compatible with human serum.
Conjugation to latex particles using conventional methodology is complex and time-consuming, and typically requires extensive optimisation and relatively large quantities of antibody, with aggregation often a major problem associated with covalent conjugations, and extensive pH optimisation required for passive conjugation techniques.
Dr Nick Gee, CEO of Innova Biosciences, commented: “Innova developed the new LATEX conjugation kits in response to customer feedback on the need for a quick and easy alternative to conventional methods. The new kits build upon Innova’s quickly expanding particle range, offering increased flexibility to those working within the diagnostics field.”
For more information please visit https://www.innovabiosciences.com/latex-conjugation-kits.html